Autophagy in premature senescent cells is activated via AMPK pathway

International Journal of Molecular Sciences

Volumn 13, Issue 3, 2012, Pages 3563-3582

  Guo, Liujing ^a   Xie, Bushan ^b   Mao, Zebin ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b NANCHANG UNIVERSITY   (China)

Author keywords

AMPK; Apoptosis; Autophagy; Fibroblasts; FoxO3A; Senescent cells

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADENYLATE KINASE; BECLIN 1; HYDROGEN PEROXIDE; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE LKB1; PYRUVATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE KINASE 4; S6 KINASE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FKHRL1; FORKHEAD TRANSCRIPTION FACTOR; FOXO3 PROTEIN, HUMAN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MTOR PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; PYRUVATE DEHYDROGENASE (ACETYL-TRANSFERRING) KINASE; PYRUVATE DEHYDROGENASE COMPLEX; TARGET OF RAPAMYCIN KINASE;

APOPTOSIS; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CELL AGING; CELL PROTECTION; CELL STRESS; CELL STRUCTURE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION REGULATION; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; AMP-ACTIVATED PROTEIN KINASES; APOPTOSIS; AUTOPHAGY; CELL AGING; CELL PROLIFERATION; CELLS, CULTURED; ENZYME ACTIVATION; FIBROBLASTS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; HYDROGEN PEROXIDE; PROTEIN-SERINE-THREONINE KINASES; PYRUVATE DEHYDROGENASE COMPLEX; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84858959012     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms13033563     Document Type: Article

References (42)

1. Serrano, M.; Blasco, M.A. Putting the stress on senescence. Curr. Opin. Cell Biol. 2001, 13, 748-753.
2. Roninson, I.B. Tumor cell senescence in cancer treatment. Cancer Res. 2003, 63, 2705-2715.
3. KIP1 in retinoblastoma protein-mediated senescence. Mol. Cell. Biol. 2001, 21, 3616-3631.
4. Sager, R. Senescence as a mode of tumor suppression. Environ. Health Persp. 1991, 93, 59-62.
5. Campisi, J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol. 2001, 11, S27-S31.
6. Donehower, L.A.; Harvey, M.; Slagle, B.L.; Mcarthur, M.J.; Montgomery, C.A.; Butel, J.S.; Bradley, A. Mice deficient for P53 are developmentally normal but susceptible to spontaneous tumors. Nature 1992, 356, 215-221.
7. Ghebranious, N.; Donehower, L.A. Mouse models in tumor suppression. Oncogene 1998, 17, 3385-3400.
8. Wang, C.W.; Klionsky, D.J. The molecular mechanism of autophagy. Mol. Med. 2003, 9, 65-76.
9. Mizushima, N.; Levine, B.; Cuervo, A.M.; Klionsky, D.J. Autophagy fights disease through cellular self-digestion. Nature 2008, 451, 1069-1075.
10. Herman-Antosiewicz, A.; Johnson, D.E.; Singh, S.V. Sulforaphane causes autophagy to inhibit release of cytochrome c and apoptosis in human prostate cancer cells. Cancer Res. 2006, 66, 5828-5835.
11. Lu, X.F.; Jiang, X.G.; Lu, Y.B.; Bai, J.H.; Mao, Z.B. Characterization of a novel positive transcription regulatory element that differentially regulates the insulin-like growth factor binding protein-3 (IGFBP-3) gene in senescent cells. J. Biol. Chem. 2005, 280, 22606-22615.
12. Bursch, W.; Ellinger, A.; Kienzl, H.; Torok, L.; Pandey, S.; Sikorska, M.; Walker, R.; Hermann, R.S. Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: The role of autophagy. Carcinogenesis 1996, 17, 1595-1607.
13. Shimizu, S.; Kanaseki, T.; Mizushima, N.; Mizuta, T.; Arakawa-Kobayashi, S.; Thompson, C.B.; Tsujimoto, Y. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat. Cell Biol. 2004, 6, 1221-1228.
14. Stroikin, Y.; Dalen, H.; Brunk, U.T.; Terman, A. Testing the "garbage" accumulation theory of ageing: Mitotic activity protects cells from death induced by inhibition of autophagy. Biogerontology 2005, 6, 39-47.
15. Gerland, L.M.; Peyrol, S.; Lallemand, C.; Branche, R.; Magaud, J.P.; Ffrench, M. Association of increased autophagic inclusions labeled for beta-galactosidase with fibroblastic aging. Exp. Gerontol. 2003, 38, 887-895.
16. Biederbick, A.; Kern, H.F.; Elsasser, H.P. Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles. Eur. J. Cell Biol. 1995, 66, 3-14.
17. Mizushima, N. Methods for monitoring autophagy. Int. J. Biochem. Cell Biol. 2004, 36, 2491-2502.
18. Petiot, A.; Ogier-Denis, E.; Blommaart, E.F.; Meijer, A.J.; Codogno, P. Distinct classes of phosphatidylinositol 3'-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J. Biol. Chem. 2000, 275, 992-998.
19. Kihara, A.; Kabeya, Y.; Ohsumi, Y.; Yoshimori, T. Beclin-phosphatidylinositol 3-kinase complex functions at the trans-Golgi network. EMBO Rep. 2001, 2, 330-335.
20. Tassa, A.; Roux, M.P.; Attaix, D.; Bechet, D.M. Class III phosphoinositide 3-kinase-Beclin1 complex mediates the amino acid-dependent regulation of autophagy in C2C12 myotubes. Biochem. J. 2003, 376, 577-586.
21. Liang, X.H.; Yu, J.; Brown, K.; Levine, B. Beclin 1 contains a leucine-rich nuclear export signal that is required for its autophagy and tumor suppressor function. Cancer Res. 2001, 61, 3443-3449.
22. Ravikumar, B.; Vacher, C.; Berger, Z.; Davies, J.E.; Luo, S.; Oroz, L.G.; Scaravilli, F.; Easton, D.F.; Duden, R.; O'Kane, C.J.; Rubinsztein, D.C. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 2004, 36, 585-595.
23. Inoki, K.; Zhu, T.; Guan, K.L. TSC2 mediates cellular energy response to control cell growth and survival. Cell 2003, 115, 577-590.
24. Brugarolas, J.; Lei, K.; Hurley, R.L.; Manning, B.D.; Reiling, J.H.; Hafen, E.; Witters, L.A.; Ellisen, L.W.; Kaelin, W.G., Jr. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev. 2004, 18, 2893-2904.
25. Pullen, N.; Thomas, G. The modular phosphorylation and activation of p70s6k. FEBS Lett. 1997, 410, 78-82.
26. Arsham, A.M.; Neufeld, T.P. Thinking globally and acting locally with TOR. Curr. Opin. Cell Biol. 2006, 18, 589-597.
27. Hardie, D.G. The AMP-activated protein kinase pathway-new players upstream and downstream. J. Cell Sci. 2004, 117, 5479-5487.
28. Alessi, D.R.; Andjelkovic, M.; Caudwell, B.; Cron, P.; Morrice, N.; Cohen, P.; Hemmings, B.A. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 1996, 15, 6541-6551.
29. Shaw, R.J.; Kosmatka, M.; Bardeesy, N.; Hurley, R.L.; Witters, L.A.; DePinho, R.A.; Cantley, L.C. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc. Natl. Acad. Sci. USA 2004, 101, 3329-3335.
30. Shaw, R.J.; Lamia, K.A.; Vasquez, D.; Koo, S.H.; Bardeesy, N.; Depinho, R.A.; Montminy, M.; Cantley, L.C. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 2005, 310, 1642-1646.
31. Sugden, M.C.; Holness, M.J. Mechanisms underlying regulation of the expression and activities of the mammalian pyruvate dehydrogenase kinases. Arch. Physiol. Biochem. 2006, 112, 139-149.
32. Kwon, H.S.; Huang, B.; Unterman, T.G.; Harris, R.A. Protein kinase B-alpha inhibits human pyruvate dehydrogenase kinase-4 gene induction by dexamethasone through inactivation of FOXO transcription factors. Diabetes 2004, 53, 899-910.
33. Jia, K.; Chen, D.; Riddle, D.L. The TOR pathway interacts with the insulin signaling pathway to regulate C. elegans larval development, metabolism and life span. Dev. Biol. 2004, 131, 3897-3906.
34. Wu, A.L.; Kim, J.H.; Zhang, C.; Unterman, T.G.; Chen, J. Forkhead box protein O1 negatively regulates skeletal myocyte differentiation through degradation of mammalian target of rapamycin pathway components. Endocrinology 2008, 149, 1407-1414.
35. Southgate, R.J.; Neill, B.; Prelovsek, O.; El-Osta, A.; Kamei, Y.; Miura, S.; Ezaki, O.; McLoughlin, T.J.; Zhang, W.; Unterman, T.G.; Febbraio, M.A. FOXO1 regulates the expression of 4E-BP1 and inhibits mTOR signaling in mammalian skeletal muscle. J. Biol. Chem. 2007, 282, 21176-21186.
36. Mammucari, C.; Milan, G.; Romanello, V.; Masiero, E.; Rudolf, R.; Del Piccolo, P.; Burden, S.J.; di Lisi, R.; Sandri, C.; Zhao, J.; Goldberg, A.L.; Schiaffino, S.; Sandri, M. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab. 2007, 6, 458-471.
37. Zhao, J.; Brault, J.J.; Schild, A.; Cao, P.; Sandri, M.; Schiaffino, S.; Lecker, S.H.; Goldberg, A.L. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab. 2007, 6, 472-483.
38. Calnan, D.R.; Brunet, A. The FoxO code. Oncogene 2008, 27, 2276-2288.
39. Wang, Y.; Meng, A.; Zhou, D. Inhibition of phosphatidylinostol 3-kinase uncouples H2O2-induced senescent phenotype and cell cycle arrest in normal human diploid fibroblasts. Exp. Cell Res. 2004, 298, 188-196.
40. Courtois-Cox, S.; Genther Williams, S.M.; Reczek, E.E.; Johnson, B.W.; McGillicuddy, L.T.; Johannessen, C.M.; Hollstein, P.E.; MacCollin, M.; Cichowski, K. A negative feedback signaling network underlies oncogene-induced senescence. Cancer Cell. 2006, 10, 459-472.
41. Mawal-Dewan, M.; Lorenzini, A.; Frisoni, L.; Zhang, H.; Cristofalo, V.J.; Sell, C. Regulation of collagenase expression during replicative senescence in human fibroblasts by Akt-forkhead signaling. J. Biol. Chem. 2002, 277, 7857-7864.
42. Huang, H.; Tindall, D.J. Dynamic FoxO transcription factors. J. Cell Sci. 2007, 120, 2479-2487.